These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 27646492

  • 1. Impact of maternal steroids during pregnancy.
    Reynolds RM.
    Ann Endocrinol (Paris); 2016 Dec; 77(6):677-679. PubMed ID: 27646492
    [Abstract] [Full Text] [Related]

  • 2. Glucocorticoid excess and the developmental origins of disease: two decades of testing the hypothesis--2012 Curt Richter Award Winner.
    Reynolds RM.
    Psychoneuroendocrinology; 2013 Jan; 38(1):1-11. PubMed ID: 22998948
    [Abstract] [Full Text] [Related]

  • 3. Early-life glucocorticoid exposure: the hypothalamic-pituitary-adrenal axis, placental function, and long-term disease risk.
    Braun T, Challis JR, Newnham JP, Sloboda DM.
    Endocr Rev; 2013 Dec; 34(6):885-916. PubMed ID: 23970762
    [Abstract] [Full Text] [Related]

  • 4. Programming effects of glucocorticoids.
    Reynolds RM.
    Clin Obstet Gynecol; 2013 Sep; 56(3):602-9. PubMed ID: 23722920
    [Abstract] [Full Text] [Related]

  • 5. Do alterations in placental 11beta-hydroxysteroid dehydrogenase (11betaHSD) activities explain differences in fetal hypothalamic-pituitary-adrenal (HPA) function following periconceptional undernutrition or twinning in sheep?
    Connor KL, Challis JR, van Zijl P, Rumball CW, Alix S, Jaquiery AL, Oliver MH, Harding JE, Bloomfield FH.
    Reprod Sci; 2009 Dec; 16(12):1201-12. PubMed ID: 19767539
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms of disease: glucocorticoids, their placental metabolism and fetal 'programming' of adult pathophysiology.
    Seckl JR, Holmes MC.
    Nat Clin Pract Endocrinol Metab; 2007 Jun; 3(6):479-88. PubMed ID: 17515892
    [Abstract] [Full Text] [Related]

  • 7. Ethanol-induced inhibition of fetal hypothalamic-pituitary-adrenal axis due to prenatal overexposure to maternal glucocorticoid in mice.
    Liang G, Chen M, Pan XL, Zheng J, Wang H.
    Exp Toxicol Pathol; 2011 Nov; 63(7-8):607-11. PubMed ID: 20627497
    [Abstract] [Full Text] [Related]

  • 8. Glucocorticoid programming.
    Seckl JR, Meaney MJ.
    Ann N Y Acad Sci; 2004 Dec; 1032():63-84. PubMed ID: 15677396
    [Abstract] [Full Text] [Related]

  • 9. The Hypothalamic-Pituitary-Adrenal Axis and the Fetus.
    Morsi A, DeFranco D, Witchel SF.
    Horm Res Paediatr; 2018 Dec; 89(5):380-387. PubMed ID: 29874660
    [Abstract] [Full Text] [Related]

  • 10. The impact of maternal synthetic glucocorticoid administration in late pregnancy on fetal and early neonatal hypothalamic-pituitary-adrenal axes regulatory genes is dependent upon dose and gestational age at exposure.
    Li S, Moss TJ, Nitsos I, Matthews SG, Challis JR, Newnham JP, Sloboda DM.
    J Dev Orig Health Dis; 2013 Feb; 4(1):77-89. PubMed ID: 25080184
    [Abstract] [Full Text] [Related]

  • 11. Nicotine-induced over-exposure to maternal glucocorticoid and activated glucocorticoid metabolism causes hypothalamic-pituitary-adrenal axis-associated neuroendocrine metabolic alterations in fetal rats.
    Xu D, Liang G, Yan YE, He WW, Liu YS, Chen LB, Magdalou J, Wang H.
    Toxicol Lett; 2012 Mar 25; 209(3):282-90. PubMed ID: 22265867
    [Abstract] [Full Text] [Related]

  • 12. Foetal and placental 11β-HSD2: a hub for developmental programming.
    Cottrell EC, Seckl JR, Holmes MC, Wyrwoll CS.
    Acta Physiol (Oxf); 2014 Feb 25; 210(2):288-95. PubMed ID: 24330050
    [Abstract] [Full Text] [Related]

  • 13. Glucocorticoids, 11beta-hydroxysteroid dehydrogenase, and fetal programming.
    Seckl JR, Cleasby M, Nyirenda MJ.
    Kidney Int; 2000 Apr 25; 57(4):1412-7. PubMed ID: 10760076
    [Abstract] [Full Text] [Related]

  • 14. Sex-specific and lasting effects of a single course of antenatal betamethasone treatment on human placental 11β-HSD2.
    Braun F, Hardt AK, Ehrlich L, Sloboda DM, Challis JRG, Plagemann A, Henrich W, Braun T.
    Placenta; 2018 Sep 25; 69():9-19. PubMed ID: 30213491
    [Abstract] [Full Text] [Related]

  • 15. Programming of the hypothalamo-pituitary-adrenal axis and the fetal origins of adult disease hypothesis.
    Clark PM.
    Eur J Pediatr; 1998 Jan 25; 157 Suppl 1():S7-10. PubMed ID: 9462899
    [Abstract] [Full Text] [Related]

  • 16. Long-term effects of prenatal stress and glucocorticoid exposure.
    Painter RC, Roseboom TJ, de Rooij SR.
    Birth Defects Res C Embryo Today; 2012 Dec 25; 96(4):315-24. PubMed ID: 24203920
    [Abstract] [Full Text] [Related]

  • 17. Reconciling the nutritional and glucocorticoid hypotheses of fetal programming.
    Cottrell EC, Holmes MC, Livingstone DE, Kenyon CJ, Seckl JR.
    FASEB J; 2012 May 25; 26(5):1866-74. PubMed ID: 22321728
    [Abstract] [Full Text] [Related]

  • 18. Glucocorticoid exposure and tissue gene expression of 11beta HSD-1, 11beta HSD-2, and glucocorticoid receptor in a porcine model of differential fetal growth.
    McNeil CJ, Nwagwu MO, Finch AM, Page KR, Thain A, McArdle HJ, Ashworth CJ.
    Reproduction; 2007 Mar 25; 133(3):653-61. PubMed ID: 17379659
    [Abstract] [Full Text] [Related]

  • 19. Antenatal endogenous and exogenous glucocorticoids and their impact on immune ontogeny and long-term immunity.
    Solano ME, Holmes MC, Mittelstadt PR, Chapman KE, Tolosa E.
    Semin Immunopathol; 2016 Nov 25; 38(6):739-763. PubMed ID: 27465226
    [Abstract] [Full Text] [Related]

  • 20. Nick Hales Award Lecture 2011: glucocorticoids and early life programming of cardiometabolic disease.
    Reynolds RM.
    J Dev Orig Health Dis; 2012 Oct 25; 3(5):309-14. PubMed ID: 25102258
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.